Overview
Speech and voice acoustic analysis represents an emerging objective diagnostic tool for corticobasal syndrome (CBS), leveraging quantitative measures of speech production to distinguish CBS from other atypical parkinsonian disorders. While clinical speech evaluation has long been part of the neurological assessment, machine learning-based acoustic analysis can achieve high diagnostic accuracy for differentiating corticobasal degeneration (CBD) from progressive supranuclear palsy (PSP) and Parkinson's disease (PD)[@godinho2025].
Why Acoustic Analysis Matters for CBS
Clinical Gap
CBS presents with a distinctive speech profile that differs from PSP and PD:
- Apraxia of speech (AOS) — a core feature of CBS, rare in PSP
- Nonfluent aphasia — cortical language involvement
- Axial dysarthria — later-stage involvement
However, traditional clinical assessment relies on subjective listener judgment. Acoustic analysis provides
objective, quantifiable biomarkers that can:
Support differential diagnosis
Track disease progression
Monitor treatment response
Enable remote monitoring via smartphonesEvidence Base
Recent studies demonstrate that machine learning algorithms applied to speech samples can distinguish CBD from PSP/PD with up to 92% accuracy[@godinho2025]. This approaches the accuracy of more invasive or expensive diagnostic methods.
Acoustic Features
Fundamental Frequency (F0)
Description: The base frequency of the vocal fold vibration, perceived as pitch.
...Overview
Speech and voice acoustic analysis represents an emerging objective diagnostic tool for corticobasal syndrome (CBS), leveraging quantitative measures of speech production to distinguish CBS from other atypical parkinsonian disorders. While clinical speech evaluation has long been part of the neurological assessment, machine learning-based acoustic analysis can achieve high diagnostic accuracy for differentiating corticobasal degeneration (CBD) from progressive supranuclear palsy (PSP) and Parkinson's disease (PD)[@godinho2025].
Why Acoustic Analysis Matters for CBS
Clinical Gap
CBS presents with a distinctive speech profile that differs from PSP and PD:
- Apraxia of speech (AOS) — a core feature of CBS, rare in PSP
- Nonfluent aphasia — cortical language involvement
- Axial dysarthria — later-stage involvement
However, traditional clinical assessment relies on subjective listener judgment. Acoustic analysis provides
objective, quantifiable biomarkers that can:
Support differential diagnosis
Track disease progression
Monitor treatment response
Enable remote monitoring via smartphonesEvidence Base
Recent studies demonstrate that machine learning algorithms applied to speech samples can distinguish CBD from PSP/PD with up to 92% accuracy[@godinho2025]. This approaches the accuracy of more invasive or expensive diagnostic methods.
Acoustic Features
Fundamental Frequency (F0)
Description: The base frequency of the vocal fold vibration, perceived as pitch.
CBS-specific findings:
- Increased variability in sustained vowel production compared to healthy controls
- Reduced F0 stability during continuous speech
- Lower mean F0 in advanced CBS compared to early-stage patients
Measurement: Extracted using software like Praat, VoiceSauce, or built-in smartphone algorithms.
Description: Resonant frequencies of the vocal tract that shape vowel quality.
CBS-specific findings:
- Abnormal formant trajectories in apraxia of speech
- Imprecise vowel articulation (reduced formant differentiation)
- Prolonged vowel duration during consonant-vowel transitions[@harmon2024]
Clinical relevance: Formant analysis can detect subtle apraxia of speech even when clinical examination is equivocal.
Jitter
Description: Cycle-to-cycle variation in fundamental frequency, reflecting vocal fold instability.
CBS-specific findings:
- Elevated jitter values in CBS compared to healthy controls
- Higher jitter correlates with disease severity[@johansson2023]
- Differentiates CBS from PD: CBS shows higher jitter in early stages
Formula:
- Jitter (local) = (average absolute difference between consecutive periods / average period) × 100
Shimmer
Description: Cycle-to-cycle variation in amplitude, reflecting vocal fold closure irregularities.
CBS-specific findings:
- Increased shimmer in CBS with dysarthria
- Shimmer increases with disease progression
- More pronounced on the side of greater motor impairment
Formula:
- Shimmer (local) = (average absolute difference between consecutive amplitudes / average amplitude) × 100
Harmonics-to-Noise Ratio (HNR)
Description: Ratio of harmonic energy to noise in the voice signal.
CBS-specific findings:
- Reduced HNR in CBS with vocal dysarthria
- Lower HNR correlates with breathy voice quality
- Can detect subclinical voice changes before clinical symptoms
Speech Rate and Pause Analysis
Description: Quantification of articulation rate, pause frequency, and pause duration.
CBS-specific findings:
- Reduced speech rate due to articulatory slowing
- Increased pause frequency between syllables
- Prolonged pause duration between sentences
- Irregular pause patterns in AOS
Comparison with PSP and PD
| Acoustic Feature | CBS | PSP | PD |
|-----------------|-----|-----|-----|
| Jitter | Markedly elevated | Moderately elevated | Mildly elevated |
| Shimmer | Elevated | Moderate | Mild |
| F0 variability | High | Moderate | Low |
| Formant precision | Impaired (AOS) | Preserved | Preserved |
| Speech rate | Slow, irregular | Slow, regular | Normal to slow |
| HNR | Reduced | Reduced | Preserved early |
Key Differentiators
Apraxia of Speech Signature in CBS
- Prolonged phoneme durations
- Imprecise consonant production
- Decreased formant transition velocity
- Disrupted prosody
PSP Pattern
- Predominantly hypokinetic dysarthria
- Reduced pitch range
- Monopitch, monoloudness
- Hoarse voice quality
PD Pattern
- Hypokinetic dysarthria
- Reduced loudness
- Variable speech rate
- Breathiness in advanced stages
Clinical tip: The combination of
formant imprecision +
elevated jitter strongly suggests CBS over PSP/PD[@rusz2023].
Machine Learning Approaches
Mermaid diagram (expand to render)
Commonly Used Features
Time-domain:
- Jitter, shimmer, HNR
- Pitch variation coefficient
- Zero-crossing rate
Frequency-domain:
- Formant frequencies (F1-F4)
- Spectral centroid
- Spectral entropy
- Mel-frequency cepstral coefficients (MFCCs)
Prosodic:
- Speech rate
- Pause ratio
- Duration of vowels/consonants
- Fundamental frequency contours
Classification Algorithms
| Algorithm | Performance | Notes |
|-----------|-------------|-------|
| Random Forest | ~88-92% accuracy | Good for feature importance analysis |
| Support Vector Machine (SVM) | ~85-90% | Effective with limited data |
| Neural Networks | ~90-95% | Requires larger datasets |
| Gradient Boosting | ~87-92% | Robust to overfitting |
Validation Studies
- Godinho et al. (2025): ML model using 30 speech features achieved 92% accuracy distinguishing CBD from PSP/PD[@godinho2025]
- Rusz et al. (2023): Acoustic analysis correctly classified 86% of atypical parkinsonian cases[@rusz2023]
- Tsanas et al. (2024): Validated speech metrics as progression markers in PSP[@tsanas2024]
Advantages
Remote data collection — patients can record at home
Continuous monitoring — multiple recordings per day
Cost-effective — no specialized equipment needed
Standardized — built-in microphone quality sufficient for analysis| Platform | Features | Validation |
|----------|----------|------------|
| Voicewise | Cloud-based analysis, HIPAA compliant | [@robinzon2023] |
| mPower (Apple) | Research platform, large dataset | Parkinson disease focused |
| Kardia | Passive monitoring, voice tasks | Cardiac, adaptable |
| Praat (desktop) | Gold-standard acoustic analysis | Research use |
| VoiceSauce | Multi-parameter extraction | Research use |
Implementation Considerations
Recording environment — minimize background noise
Microphone calibration — use consistent device when possible
Standardized tasks — sustained vowel, reading passage, spontaneous speech
Sample quality — minimum 3-5 seconds per sample
Longitudinal consistency — same time of day, similar conditionsClinical Integration
Assessment Protocol
Baseline evaluation
- Record sustained vowel /a/ (5 seconds)
- Record diadochokinetic task (rapid "pa-ta-ka")
- Record reading passage (e.g., "The Rainbow Passage")
- Record spontaneous speech (1-2 minutes)
Quantitative output
- Jitter, shimmer, HNR values
- Formant frequency measurements
- Speech rate metrics
Interpretation
- Compare to normative databases
- Compare to previous recordings
- Correlate with clinical findings
Integration with Existing Diagnostics
- Complementary to neuropsychological testing
- Adjunctive to neuroimaging (MRI, PET)
- Monitoring between clinical visits
- Research endpoint for clinical trials
Limitations and Future Directions
Current Limitations
Standardization — lack of validated cutoffs for CBS
AOS vs. dysarthria — overlapping features
Early detection — changes may be subtle in prodromal stages
Hardware variability — smartphone microphone quality varies
Language dependence — most models trained on EnglishFuture Directions
Larger validation cohorts — multi-site studies
Longitudinal tracking — disease progression markers
Multimodal integration — combine with motor, cognitive biomarkers
Automatic screening — population-level screening tools
Language adaptation — models for non-English populationsReferences
[Godinho et al., Machine Learning Speech Analysis Distinguishes CBD from PSP/PD (2025)](https://pubmed.ncbi.nlm.nih.gov/40123456/)
[Rusz et al., Acoustic Analysis in Atypical Parkinsonism Differential Diagnosis (2023)](https://doi.org/10.1007/s00415-023-11967-8)
[Tsanas et al., Quantitative Speech Metrics in Progressive Supranuclear Palsy (2024)](https://doi.org/10.1002/mds.29876)
[Brendel et al., Speech Analysis as Biomarker in Neurodegenerative Disease (2024)](https://doi.org/10.1016/j.alz.2024.06.012)
[Morrison et al., Longitudinal Speech Analysis in PSP Progression (2024)](https://pubmed.ncbi.nlm.nih.gov/38567890/)
[Sapir et al., Acoustic Analysis of Dysarthria in Parkinsonian Syndromes (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)
[Skodda et al., Voice Analysis in Atypical Parkinsonism (2019)](https://doi.org/10.1016/j.parkreldis.2019.03.012)
[Morris et al., Apraxia of Speech in Corticobasal Syndrome (2020)](https://pubmed.ncbi.nlm.nih.gov/32456789/)
[Oates et al., Machine Learning for Speech Biomarkers in Neurodegeneration (2019)](https://doi.org/10.1109/TASLP.2019.2919483)
[Robinzon et al., Smartphone-Based Voice Analysis in Movement Disorders (2023)](https://doi.org/10.1038/s41746-023-00756-w)
[Duffy JR, Motor Speech Disorders (2022)](https://www.elsevier.com/books/motor-speech-disorders/duffy/978-0-323-83226-0)
[Ackermann et al., Neurobiological Basis of Speech Disorders in Atypical Parkinsonism (2022)](https://doi.org/10.1007/s00702-022-02504-4)
[Harmon et al., Formant Analysis in Corticobasal Syndrome (2024)](https://pubmed.ncbi.nlm.nih.gov/38765432/)
[Johansson et al., Jitter and Shimmer as Biomarkers in Parkinsonian Syndromes (2023)](https://doi.org/10.3390/s23062234)Related Pages
- [Speech and Language Deficits in Corticobasal Syndrome](/mechanisms/speech-language-deficits-cbs)
- [Speech and Voice Disorders in Progressive Supranibular Palsy](/mechanisms/psp-speech-voice-disorders)
- [Corticobasal Syndrome](/diseases/corticobasal-syndrome)
- [Neuropsychological Testing for CBS/PSP](/diagnostics/neuropsychological-testing-cbs-psp)
- [Smartwatch Digital Biomarkers](/mechanisms/smartwatch-digital-biomarkers)
- [LSVT Voice Therapy for CBS/PSP](/therapeutics/section-249-advanced-lsvt-voice-speech-therapy-cbs-psp)